FSD Pharma News

FSD Pharma Trials Supplement for Alcohol Intoxication

TipRanks14:38 ET

DEA Moving To Reclassify Marijuana As Less Dangerous Drug

DEA Moving To Reclassify Marijuana As Less Dangerous Drug

Benzinga13:07 ET

FSD Pharma Signs Agreement With Applied Science And Performance Institute To Conduct A Clinical Trial In The U.S. To Assess The Safety And Efficacy Of 'Unbuzzd' In An Induced State Of Alcohol Intoxication

FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" of the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the trea

BenzingaApr 30 08:46 ET

Express News | Watching Shares Of Marijuana Stocks; Traders Circulate Comments From The TDR Podcast Saying "We've Heard Rumors That Potentially That Announcement Could Be Coming This Week - Whatever The Decision May Be", "I'm Hearing From Some Sources That Pro-Marijuana

BenzingaApr 29 13:41 ET

FSD Pharma Says Celly Nutrition Partners With Six+One for US Launch of Dietary Supplement

FSD Pharma (HUGE) said Thursday that Celly Nutrition has partnered with branding agency Six+One to collaborate on the launch of its dietary supplement unbuzzd in the US. As part of the collaboration,

MT NewswiresApr 25 13:50 ET

FSD Pharma's Unbuzzd Gears Up for U.S. Launch

TipRanksApr 25 08:07 ET

FSD Pharma Provides Update From Celly Nu's Partnership With Six+One For Beverage Product Unbuzzd

On April 25, 2024, Celly Nu announced a strategic partnership with Six+One, a purpose-driven branding, advertising, and production agency based in New York City. FSD Pharma has also licensed unbuzzd,

BenzingaApr 25 07:58 ET

FSD Pharma Gears Up for Unbuzzd US Launch

TipRanksApr 22 08:38 ET

FSD Pharma Provides Another Update on Celly Nu's Anticipated Launch of Unbuzzd(TM)

On April 22, 2024, Celly Nu announced a strategic partnership with BevSource, a leading provider of beverage development, production and operations solutions in St. Paul, Minnesota as follows.

AccesswireApr 22 08:02 ET

Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More

Welcome to Benzinga's psychedelic headlines roundup. This is our pick of must-read news items from the first two weeks of April 2024.See previous edition Psychedelics Headlines: A Form Of Life, Treati

BenzingaApr 17 09:13 ET

Express News | FSD Pharma Says It Has Initiated Investigations Into Ingredients And Dietary Supplements That May Have The Potential To Promote Weight Loss And Liver Health

Moomoo 24/7Apr 17 08:05 ET

FSD Pharma Increases Stake in Recovery Drink Innovator

TipRanksApr 15 08:47 ET

FSD Pharma Provides Update on Its Investment in Celly Nutrition Corp., a Company Launching a Product That Can Assist in Expediting Alcohol Metabolism and Faster Recovery From Alcohol Consumption

On April 8, 2024, Celly Nu announced an investment by FSD complete press release is referenced below;

AccesswireApr 15 08:03 ET

Express News | 'FDA Head Says There's 'No Reason For DEA To Delay' Rescheduling Marijuana' - Marijuana Moment

Moomoo 24/7Apr 11 14:14 ET

FSD Pharma Faces Nasdaq Compliance Challenge

TipRanksApr 9 17:28 ET

FSD Pharma Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

Seeking AlphaApr 8 05:52 ET

FSD Pharma Receives Nasdaq Non-Compliance Notice

FSD Pharma (HUGE) said it received an April 5 notice from Nasdaq informing it that the company has fallen out of compliance with rules requiring a $1 minimum share price for being listed on the exchan

MT NewswiresApr 8 04:58 ET

FSD Pharma Inc. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

Toronto, Ontario--(Newsfile Corp. - April 7, 2024) - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9) ("FSD Pharma" or the "Company"), a biopharmaceutical company dedicated to building a portfoli

newsfileApr 7 22:55 ET

FSD Pharma GAAP EPS of -$0.46

Seeking AlphaApr 2 06:00 ET

FSD Pharma Reports Year-End Financials & R&D Progress

TipRanksApr 1 22:37 ET